These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1529977)

  • 1. Comments on the ADD-Vantage system.
    Boylan JC
    Am J Hosp Pharm; 1992 Jun; 49(6):1396-7; author reply 1397-8. PubMed ID: 1529977
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the ADD-vantage system.
    Robertson C; Schannuth R
    Am J Hosp Pharm; 1992 Jun; 49(6):1397. PubMed ID: 1529978
    [No Abstract]   [Full Text] [Related]  

  • 3. Compliance policy guide addresses prescription drug compounding.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611176
    [No Abstract]   [Full Text] [Related]  

  • 4. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposed current good manufacturing practice and supplemental regulations.
    Korun FD
    Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432
    [No Abstract]   [Full Text] [Related]  

  • 6. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 7. Formulation/manufacturing: a basic bibliography (#51).
    Moores KG; Lange PG
    Hosp Pharm; 1988 Nov; 23(11):1039. PubMed ID: 10302983
    [No Abstract]   [Full Text] [Related]  

  • 8. [Round table on the "norms for good drug compounding"].
    Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 10. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical controls for drug availability.
    Bethel RF
    Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 15. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assurance and parenterals.
    Beall D
    Bull Parenter Drug Assoc; 1970; 24(4):176-82. PubMed ID: 5431585
    [No Abstract]   [Full Text] [Related]  

  • 17. When does compounding become manufacturing?
    Gushee J
    J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585
    [No Abstract]   [Full Text] [Related]  

  • 18. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 19. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.